About Us

Raising CRO standards for innovation and delivery to help bring life-changing treatments to patients faster.

Advancing rare disease clinical trials and orphan drug research: A focus on APAC and China

Explore Fortrea's advancements in rare disease clinical trials and orphan drug research. Read our blog for insights into our innovative research solutions.

Effective planning to address unmet needs in Prader-Willi Syndrome trials

Prader-Willi Syndrome (PWS) is the most common genetic cause of life-threatening obesity. Occurring in close to one out of every 15,000 births, PWS currently has no cure and consists of chronic overeating, mild to moderate intellectual impairment and compulsive behavioral problems.

Creating patient- and site-centric solutions for a challenging antibiotic study

A pharmaceutical company partnered with Fortrea to support their Phase 1b pharmacokinetic clinical trial of a new antibiotic candidate for life-threatening nosocomial infections, including drug-resistant infections. 

Implementing agile solutions to successfully deliver a vaccine clinical trial in China

Achieving diversity in drug development programs for obesity

Diversity action plans

Anti-obesity drug development: advances, challenges and mitigations to maximize success

Advances, challenges and mitigation to maximize success

Enhancing endpoint protection in pain management clinical trials

Key considerations for endpoint protection in pain management clinical trials

Parkinson’s disease: multiple ascending dose

Collaborative communication helped meet sponsor’s milestones and maintain patient safety